Publication | Closed Access

Erlotinib in combination with capecitabine and docetaxel in patients with metastatic breast cancer: A dose-escalation study

Dose-escalation StudyMetastatic Breast CancerOncologyBreast OncologyPharmacologyBreast CancerPharmacotherapyAnti-cancer AgentCancer TreatmentMedicine